JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M302430200 on July 1, 2003

J. Biol. Chem., Vol. 278, Issue 38, 35878-35888, September 19, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/38/35878    most recent
M302430200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lees, M. J.
Right arrow Articles by Whitelaw, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lees, M. J.
Right arrow Articles by Whitelaw, M. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Defining the Role for XAP2 in Stabilization of the Dioxin Receptor*

Michael J. Lees, Daniel J. Peet and Murray L. Whitelaw {ddagger}

From the School of Molecular and Biomedical Sciences (Biochemistry) and the Centre for the Molecular Genetics of Development, University of Adelaide, Adelaide, South Australia 5005, Australia

The dioxin receptor (DR) is a ligand-activated transcription factor that is activated upon binding of dioxins or structurally related forms of xenobiotics. Upon binding ligand the DR translocates from the cytoplasm to the nucleus where it complexes with the partner protein Arnt to form a DNA binding heterodimer, which activates transcription of target genes involved in xenobiotic metabolism. Latency of the DR signaling pathway is maintained by association of the DR with a number of molecular chaperones including the 90-kDa heat shock protein (hsp90), the hepatitis B virus X-associated protein (XAP2), and the 23-kDa heat shock protein (p23). Here we investigated the role of XAP2 in DR signaling and demonstrated that reduced levels of XAP2 labilize the DR, arguing for a function of XAP2 beyond its reported role as a cytoplasmic retention factor. In addition, we showed that a constitutively nuclear DR is degraded in the nucleus and does not require nuclear export for efficient degradation. We also provided evidence implicating the ubiquitin ligase protein C-terminal hsp70-interacting protein (CHIP) in the degradation of the DR, and we demonstrated that this degradation can be overcome by overexpression of XAP2. XAP2 protection of CHIP-mediated degradation is dependent on the tetratricopeptide repeat domain of XAP2 and suggests a mechanism whereby competition for the C-terminal tetratricopeptide repeat acceptor site of hsp90 guides the protein triage decision, the point of determination for either maturation of DR folding or DR degradation.


Received for publication, March 10, 2003 , and in revised form, June 17, 2003.

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} To whom correspondence should be addressed: School of Molecular and Biomedical Sciences (Biochemistry), Molecular Life Sciences Bldg., University of Adelaide, Adelaide, South Australia 5005, Australia. Tel.: 61-8-8303-4724; Fax: 61-8-8303-4348; E-mail: murray.whitelaw{at}adelaide.edu.au.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
B. C. Lin, R. Sullivan, Y. Lee, S. Moran, E. Glover, and C. A. Bradfield
Deletion of the Aryl Hydrocarbon Receptor-associated Protein 9 Leads to Cardiac Malformation and Embryonic Lethality
J. Biol. Chem., December 7, 2007; 282(49): 35924 - 35932.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
A. Beckers and A. F Daly
The clinical, pathological, and genetic features of familial isolated pituitary adenomas
Eur. J. Endocrinol., October 1, 2007; 157(4): 371 - 382.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
T. Suzuki and K. Nohara
Regulatory Factors Involved in Species-specific Modulation of Arylhydrocarbon Receptor (AhR)-dependent Gene Expression in Humans and Mice
J. Biochem., October 1, 2007; 142(4): 443 - 452.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. D. Hollingshead, R. D. Patel, and G. H. Perdew
Endogenous Hepatic Expression of the Hepatitis B Virus X-Associated Protein 2 Is Adequate for Maximal Association with Aryl Hydrocarbon Receptor-90-kDa Heat Shock Protein Complexes
Mol. Pharmacol., December 1, 2006; 70(6): 2096 - 2107.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. S. Pollenz and E. J. Dougherty
Redefining the Role of the Endogenous XAP2 and C-terminal hsp70-interacting Protein on the Endogenous Ah Receptors Expressed in Mouse and Rat Cell Lines
J. Biol. Chem., September 30, 2005; 280(39): 33346 - 33356.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. van der Spuy and M. E. Cheetham
The Leber Congenital Amaurosis Protein AIPL1 Modulates the Nuclear Translocation of NUB1 and Suppresses Inclusion Formation by NUB1 Fragments
J. Biol. Chem., November 12, 2004; 279(46): 48038 - 48047.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. D. Hollingshead, J. R. Petrulis, and G. H. Perdew
The Aryl Hydrocarbon (Ah) Receptor Transcriptional Regulator Hepatitis B Virus X-associated Protein 2 Antagonizes p23 Binding to Ah Receptor-Hsp90 Complexes and Is Dispensable for Receptor Function
J. Biol. Chem., October 29, 2004; 279(44): 45652 - 45661.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Joiakim, P. A. Mathieu, A. A. Elliott, and J. J. Reiners Jr.
Superinduction of CYP1A1 in MCF10A Cultures by Cycloheximide, Anisomycin, and Puromycin: A Process Independent of Effects on Protein Translation and Unrelated to Suppression of Aryl Hydrocarbon Receptor Proteolysis by the Proteasome
Mol. Pharmacol., October 1, 2004; 66(4): 936 - 947.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. S. Trausch-Azar, J. Lingbeck, A. Ciechanover, and A. L. Schwartz
Ubiquitin-Proteasome-mediated Degradation of Id1 Is Modulated by MyoD
J. Biol. Chem., July 30, 2004; 279(31): 32614 - 32619.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
S. Hatakeyama, M. Matsumoto, M. Yada, and K. I. Nakayama
Interaction of U-box-type ubiquitin-protein ligases (E3s) with molecular chaperones
Genes Cells, June 1, 2004; 9(6): 533 - 548.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.